Article

18 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 77, n° 5
pages 809-830 (novembre 2017)
Doi : 10.1016/j.jaad.2017.02.017
accepted : 8 February 2017
Continuing Medical Education

Spectrum of orocutaneous disease associations : Genodermatoses and inflammatory conditions
 

Elizabeth G. Wilder, MD a, Jillian Frieder, MD a, Suraj Sulhan, BA b, Pablo Michel, MD c, Jeffrey D. Cizenski, MD a, John M. Wright, DDS d, M. Alan Menter, MD a,
a Division of Dermatology, Baylor University Medical Center, Dallas, Texas 
b Texas A&M Health Science Center College of Medicine, Bryan, Texas 
c Baylor Institute for Immunology Research, Dallas, Texas 
d Texas A&M University College of Dentistry, Dallas, Texas 

Correspondence to: M. Alan Menter, MD, Division of Dermatology, Baylor University Medical Center, 3900 Junius St, Ste 145, Dallas, TX 75246.Division of DermatologyBaylor University Medical Center3900 Junius St, Ste 145DallasTX75246
Abstract

The oral cavity and cutaneous organ systems share a close embryologic origin. Therefore, there are numerous dermatologic conditions presenting with concomitant oral findings of which the dermatologist must be aware. The second article in this continuing medical education series reviews inflammatory orocutaneous conditions and a number of genodermatoses. It is essential for dermatologists to be familiar with oral cavity manifestations associated with dermatologic diseases for prompt diagnosis, management, and appropriate referral to stomatology and dentistry.

The full text of this article is available in PDF format.

Key words : amyloidosis, Behcet disease, burning mouth syndrome, cutaneous manifestations, Darier disease, genodermatoses, inflammatory, lichen planus, nevoid basal cell carcinoma syndrome, oral cavity, orocutaneous diseases, Peutz-Jeghers syndrome, sarcoidosis, sclerosis complex, tuberous erythema multiforme



 Funding sources: None.
 Dr Menter has served on the advisory board for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli-Lilly, Janssen Biotech, and LEO Pharma, been a consultant for AbbVie, Allergan, Amgen, Eli-Lilly, Galderma, Janssen Biotech, LEO Pharma, Novartis, and Pfizer, been an investigator for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Eli-Lilly, Janssen Biotech, LEO Pharma, Merck, Neothetics, Novartis, Pfizer, Regeneron, and Syntrix, and has been a speaker for AbbVie, Amgen, Janssen Biotech, and LEO Pharma. Dr Menter has received grants from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Janssen Biotech, LEO Pharma, Merck, Neothetics, Novartis, Pfizer, Regeneron, and Syntrix and has received honoraria from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli-Lilly, Galderma, Janssen Biotech, LEO Pharma, Novartis, and Pfizer. The other authors have no conflicts of interest to declare.
 Date of release: November 2017
 Expiration date: November 2020
 Reprints not available from the authors.



© 2017  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline